Company: CLIK
Filing Date: 2025-06-02
Form Type: 6-K
Source: 0001213900-25-049698
Chunk: 0

Company: Click Holdings Ltd.
Filing Date: 2025-06-02
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2025.

Commission File Number 001-42308

CLICK HOLDINGS LIMITED

(Translation of registrant’s name into English)

Unit 709, 7/F., Ocean Centre

5 Canton Road

Tsim Sha Tsui, Kowloon

Hong Kong

Telephone: +852 2691 8900

(Address of principal executive office)</div>

Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.

<div align='center'>Form 20-F ☒ Form
40-F ☐</div>

On May 30, 2025, Click Holdings Limited (the “Company”)
received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based
on the closing bid price of the Company for the period from April 16, 2025 to May 29, 2025, the Company no longer meets the continued
listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share.

Nasdaq has provided the Company with a 180 calendar
days compliance period, or until November 26, 2025, in which to regain compliance with Nasdaq continued listing requirement. If, at any
time during this compliance period, the closing bid price of the Company’s stock is at least $1.00 per share for a minimum of ten
consecutive business days, Nasdaq will confirm compliance, and the matter will be resolved.

If the Company is unable to regain compliance
by November 26, 2025, it may be eligible for additional time. To qualify, the Company will be required to meet continued listing requirement
for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of
the bid price requirement and will need to provide written notice of its intention to cure the deficiency during the second compliance
period, which may include implementing a reverse stock split, if necessary. However, if it appears that the Company will not